Peritoneal Dialysis Preparations
Peritoneal Dialysis Preparations（neutral PH）
•It applies to the peritoneal dialysis treatment of patients with chronic renal failure.
| 2,000 mL (1,600 mL of large ventricular fluid/400 mL of small ventricular fluid, glucose 1.35%) |
| 2,000 mL (1,600 mL of large ventricular fluid/400 mL of small ventricular fluid, glucose 2.5%) |
| 2,000 mL (1,600 mL of large ventricular fluid/400 mL of small ventricular fluid, glucose 1.35%) |
| 2,500 mL (2,000 mL of large ventricular fluid/500 mL of small ventricular fluid, glucose 1.35%) |
| 2,000 mL (1,600 mL of large ventricular fluid/400 mL of small ventricular fluid, glucose 2.5%) |
| 2,500 mL (2,000 mL of large ventricular fluid/500 mL of small ventricular fluid, glucose 2.5%) |
· It applies to the peritoneal dialysis treatment of patients with chronic renal failure. It is mainly used in cases where the improvement of hypermagnesemia and metabolic acidosis is insufficient and hypercalcemia may be induced by the use of calcium carbonate preparation and active vitamin D preparation.
· The neutral peritoneal dialysis fluid has the advantages of protecting patients' residual renal function and urine volume, protecting peritoneal function, relieving infusion pain, and reducing the risk of EPS (encapsulating peritoneal sclerosis) and peritonitis. Protecting patients' residual renal function and urine volume is a grade-1A recommendation in the 2020 ISPD Guidelines.
